Artificial Pancreas Systems  Market Drivers, Restraints, Share and Growth Analysis by Top Leading Players TypeZero Technologies, LLC, Beta Bionics, Dexcom, Medtronic, Johnson & Johnson, Insulet, Tandem Diabetes Care

Press Release

Global Artificial Pancreas Systems Market  By Device (Threshold Suspended Device System, CTR System, CTT System), End User (Hospitals, Clinics, Home Care, Ambulatory Center), Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa) – Industry Trends and Forecast to 2026

The artificial pancreas system is a technology that manages the sugar level in the blood, reduces T1D-related risks. The system monitors the glucose level in blood and provides substitute endocrine functionality of the pancreas. The Artificial Pancreas Device System is a system of devices that closely mimics the glucose regulating function of a healthy pancreas. A blood glucose device (such as a glucose meter) is used to calibrate the CGM. The pancreas is an organ in the body that secretes several hormones, including insulin and glucagon, as well as digestive enzymes that help break down food. Insulin helps cells in the body take up glucose (sugar) from the blood to use for energy, which lowers blood glucose levels. Glucagon causes the liver to release stored glucose, which raises blood glucose levels.

The Global Artificial Pancreas Systems Market accounted for USD 80.2 million growing at a CAGR of 7.8%during the forecast to 2026.

Get a Copy of Sample Report Now! @

Market Major Market Competitors:

TypeZero Technologies, LLC, Beta Bionics, Dexcom, Medtronic, Johnson & Johnson, Insulet, Tandem Diabetes Care, Roche, Pancreum, Bigfoot Biomedical, among others.

The data in the Artificial Pancreas Systems Market report is genuine and easy to pursue so that the readers can comprehend the market thoroughly. With the assistance of experts and various research techniques such as SWOT analysis, this well-ordered market research report has been developed. The report gives a lighting up approach to understanding the market, including insights and numbers. It gives a firm foundation that empowers numerous item engineers and specialist organizations, affiliations, organizations.

Table of Content:

Part 01: Executive Summary

Part 02: Scope of The Report

Part 03: Global Artificial Pancreas Systems Market Landscape

Part 04: Global Artificial Pancreas Systems Market Sizing

Part 05: Global Artificial Pancreas Systems Market Segmentation by Product

Part 06: Five Forces Analysis

Part 07: Customer Landscape

Part 08: Geographic Landscape

Part 09: Decision Framework

Part 10: Drivers and Challenges

Part 11: Market Trends

Part 12: Vendor Landscape

Part 13: Vendor Analysis

To Continue… For Detailed TOC | Follow @

Artificial Pancreas Systems – Competitive Analysis

The artificial pancreas systems market is highly fragmented and is based on new product launches and clinical results of products. Hence the major players have used various strategies such as new product launches, clinical trials, market initiatives, high expense on research and development, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of artificial pancreas systems market for global, Europe, North America, Asia Pacific and South America.

Market Segmentation: Artificial Pancreas Systems

  • By devices the market for artificial pancreas systems is segmented into threshold suspend device system, non-threshold suspends device system, control to range system, control to target system,
  • On the basis of end-users, the artificial pancreas systems market is segmented into hospital, clinics, home care, and ambulatory center.
  • On the basis of geography, artificial pancreas systems market report covers data points for 28 countries across multiple geographies such as North America & South America, Europe, Asia-Pacific, and Middle East & Africa. Some of the major countries covered in this report are U.S., Canada, Germany, France, U.K., Netherlands, Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia, Singapore, Saudi Arabia, South Africa, and Brazil among others. In 2017, North America is expected to dominate the market.

Major Market Drivers and Restraints:

  • Government initiatives in clinical research
  • Increasing demand for remote monitoring applications
  • Increasing demand for home care setting devices
  • Longer duration of time to completely absorb insulin
  • High initial costs for installing the equipment
  • Lack of knowledge and skilled professionals